How can European Life Sciences Compete for More Capital? - McDermott Will & Emery

How can European Life Sciences Compete for More Capital?

Overview


McDermott Will & Emery and Paris Healthcare Drinks are pleased to invite you to a round table and networking event discussing the difficulty life sciences companies can face in competing for capital and how to overcome those challenges.

The science is there, as are top researchers and outstanding companies offering disruptive technologies and products. Supportive public polices provide numerous subsidies and favorable legal frameworks… yet Europe is still lagging far behind the United States and China in terms of raising capital and attracting investors.

Can the situation change? What will trigger change for better and more accessible funding for European life sciences companies? Join us for an in depth discussion and the opportunity for interactive debate with our key speakers:

  • Marietta Wu – Managing Partner, Quan Capital
  • Thierry Laugel – Managing Partner, Kurma Partners
  • Emmanuelle Trombe – Head of the Paris Life Sciences Team, McDermott Will & Emery

For any queries, please contact Barbara Bebiano.

Dig Deeper

Webinar / McDermott IP Focus / April 6 and April 21, 2023

McDermott IP Focus (Japan) 2023

Biocom California, South San Francisco, CA / McDermott Event / April 4, 2023

Life Sciences Boot Camp for In-House Counsel 2023

Paris, France / Speaking Engagements / April 6, 23

Global Anticorruption & Compliance Summit

Madrid, Spain / Speaking Engagements / March 9, 2023

5th IBA French-Spanish Day

Brussels, Belgium / Speaking Engagements / April 17, 2023

ACC Europe | Legal Professional Privilege – Building Bridges in Europe

Webinar / Speaking Engagements / February 15, 2023

Federal And NY State Regulation Of Hemp-Based Cannabinoids